Amgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion
Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter,likely to be valued at well over $20 billion and mark the largest healthcare merger of the year.
The U.S. biotechnology company was the last of three suitors standing in an auction for Horizon, the people said, after French drugmaker Sanofi SA said Sunday it was out of the running.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Sanofi says it does not intend to make an offer for HorizonFrench health group Sanofi said on Sunday that it no longer intends to make an offer for Horizon Therapeutics Plc.
Les mer »
Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Les mer »
Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Les mer »
2022-23 New Year's Eve Celebrations in the Chicago AreaWith a new year on the horizon, it’s almost time to bid farewell to 2022.
Les mer »
Outside Voices: Preparing for inflection points in your business - Jacksonville Business JournalAs year changes, think of what changes might be on the horizon for your business.
Les mer »
WSJ News Exclusive | Juul to Pay $1.7 Billion in Legal SettlementBreaking: Juul agreed to pay $1.7 billion to settle more than 5,000 lawsuits that accused it of marketing to children and teens, according to people familiar with the matter
Les mer »